Listed

NRC Health

NRCNasdaqCIK 70487IndustrialsFiscal year ends Dec 31

Reports and events: 233 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

NRC Health, Reports and events
FiledFormWhat it isAccession number
2026-10-1910:28 ET8-K5.02 Departure or appointment of officers or directors0001437749-26-032899
2026-08-1116:31 ET8-K5.02 Departure or appointment of officers or directors0001437749-26-027031
2026-08-0414:38 ET10-QQuarterly reportPeriod 2026-06-300001437749-26-025624
2026-07-2816:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-26-024663
2026-06-2913:04 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001437749-26-021938
2026-06-1216:24 ETSCHEDULE 13D/AOwnership report, active investor, amended0001008886-26-000164
2026-05-0809:44 ETDEF 14AProxy statementPeriod 2026-06-230001437749-26-015775
2026-05-0611:42 ET10-QQuarterly reportPeriod 2026-03-310001437749-26-015083
2026-04-2817:16 ET10-K/AAnnual report, amendedPeriod 2025-12-310001437749-26-013686
2026-04-2816:03 ET8-K5.02 Departure or appointment of officers or directors0001437749-26-013646
2026-04-2816:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-26-013641
2026-04-2017:07 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001437749-26-012850
2026-03-2716:35 ETSCHEDULE 13D/AOwnership report, active investor, amended0001008886-26-000087
2026-03-0509:57 ET10-KAnnual reportPeriod 2025-12-310001437749-26-007002
2026-03-0518:12 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-26-006945
2026-02-0309:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-26-002726
2025-11-0713:03 ET10-QQuarterly reportPeriod 2025-09-300001437749-25-033793
2025-10-2717:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-25-031819
2025-08-2816:09 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001437749-25-027942
2025-08-0810:30 ET10-QQuarterly reportPeriod 2025-06-300001437749-25-025583
2025-07-2817:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-25-023676
2025-05-1209:01 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001437749-25-015965
2025-05-0910:02 ET10-QQuarterly reportPeriod 2025-03-310001437749-25-015674
2025-04-2817:12 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-25-013363
2025-04-2216:33 ET8-K5.02 Departure or appointment of officers or directors0001437749-25-012697
2025-04-1017:12 ETDEF 14AProxy statementPeriod 2025-05-070001437749-25-011693
2025-04-1016:45 ETSCHEDULE 13D/AOwnership report, active investor, amended0001008886-25-000082
2025-04-0916:33 ET8-K5.02 Departure or appointment of officers or directors0001437749-25-011529
2025-03-1710:51 ET10-KAnnual reportPeriod 2024-12-310001437749-25-007867
2025-03-0416:04 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001008886-25-000033
2025-02-1010:16 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001437749-25-003231
2025-01-2717:19 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-25-001928
2024-11-1411:19 ET8-K5.02 Departure or appointment of officers or directors0001437749-24-035132
2024-11-0811:01 ET10-QQuarterly reportPeriod 2024-09-300001437749-24-034119
2024-10-2517:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-24-032151
2024-10-1508:41 ET8-K5.02 Departure or appointment of officers or directors0001437749-24-031195
2024-08-0814:20 ET10-QQuarterly reportPeriod 2024-06-300001437749-24-025473
2024-08-0617:07 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-24-024947
2024-05-1315:20 ET8-K5.07 Shareholder vote results0001437749-24-016208
2024-05-0909:02 ET10-QQuarterly reportPeriod 2024-03-310001437749-24-015481
2024-05-0717:11 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001437749-24-015131
2024-04-1111:49 ETDEF 14AProxy statementPeriod 2024-05-080001437749-24-011731
2024-03-0516:31 ETSC 13D/AOwnership report, active investor, amended0001008886-24-000080
2024-02-2714:44 ET10-KAnnual reportPeriod 2023-12-310001437749-24-005690
2024-02-1317:07 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001437749-24-003940
2024-01-1717:00 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001437749-24-001540
2024-01-0417:05 ETSC 13D/AOwnership report, active investor, amended0001008886-24-000022
2024-01-0214:51 ET8-K5.02 Departure or appointment of officers or directors0001437749-24-000174
2023-11-0909:03 ET10-QQuarterly reportPeriod 2023-09-300001437749-23-031088
2023-11-0815:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001437749-23-030911

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:03 ET. Listed shows no prices and gives no investment advice.